Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2018
At a glance
- Drugs Perflutren (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 12 Apr 2018 Planned End Date changed from 1 Dec 2019 to 1 Feb 2019.
- 12 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Mar 2017 Status changed from not yet recruiting to recruiting.